News
-
-
-
COMMUNIQUÉ DE PRESSE
Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs
Bespak completes spin-out to form leading global CDMO focused on drug-device combination products and announces investments at Holmes Chapel site
